Can repurposing of existing drugs provide more effective therapies for invasive fungal infections?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2016-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14656566.2016.1186647PMID 27217005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

  2015cited by this paper
• In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

  2015cited by this paper
• Topical Application of Imiquimod as a Treatment for Chromoblastomycosis

  2014cited by this paper
• Antifungal drug discovery: the process and outcomes.

  2014cited by this paper
• Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis

  2014cited by this paper
• Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis.

  2014cited by this paper
• In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.

  2013cited by this paper
• Drug repurposing: translational pharmacology, chemistry, computers and the clinic.

  2013cited by this paper
• Hidden Killers: Human Fungal Infections

  2012cited by this paper
• Tackling Human Fungal Infections

  2012cited by this paper
• Antifungal Drug Discovery: Something Old and Something New

  2012cited by this paper
• Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis

  2009cited by this paper
• Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.

  2009cited by this paper
• Current challenges in the management of invasive fungal infections

  2008cited by this paper
• Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.

  2007cited by this paper
• Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis

  2006cited by this paper
• [Guidelines in paracoccidioidomycosis].

  2006cited by this paper
• Drug repositioning: identifying and developing new uses for existing drugs

  2004cited by this paper
• Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day−1) in the treatment of cutaneous or lymphocutaneous sporotrichosis

  2004cited by this paper
• Imiquimod.

  2003cited by this paper
• Treatment of cutaneous sporotrichosis with terbinafine

  1992cited by this paper

• Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches.

  2025cites this paper
• Tackling multi-drug resistant fungi by efflux pump inhibitors.

  2024cites this paper
• In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm

  2024cites this paper
• One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy

  2021cites this paper
• In Vitro and In Vivo Antifungal Activity of Buparvaquone against Sporothrix brasiliensis

  2021cites this paper
• Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans.

  2021cites this paper
• Antifungal and anti-biofilm effect of the calcium channel blocker verapamil on non-albicans Candida species.

  2020cites this paper
• The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation

  2020cites this paper
• Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges

  2020cites this paper
• Repurposing of respiratory drug theophylline against Candida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness

  2020cites this paper
• Anti-Sporothrix activity of ibuprofen combined with antifungal

  2020cites this paper
• Transcriptome Analyses of Candida albicans Biofilms, Exposed to Arachidonic Acid and Fluconazole, Indicates Potential Drug Targets

  2020cites this paper
• Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity

  2020cites this paper
• Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

  2017cites this paper
• Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis

  2017cites this paper